Live
Samsung BiologicsKorean Pharma, Biotech Firms Post Strong Q1 Sales While Profitability Diverges - thelec.netCharles RiverNeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - Yahoo FinanceInsilico MedicineInSilico Ribo Oligonucleotide Alliance Tests AI Drug Discovery Model - simplywall.stEli LillyPharma Earnings Season 2026: Amphastar Flat, Eli Lilly Surges in Q1 - News and Statistics - IndexBoxInsilico MedicineInsilico Medicine Showcases AI-Driven Inhaled Therapy for Pulmonary Fibrosis at ATS Summit - TipRanksSamsung BiologicsCDMOs turn to pharma facility acquisitions amid manufacturing realignment: GlobalData - megaproject.comThermo FisherIs It Time To Reconsider Thermo Fisher Scientific (TMO) After Its Recent Share Price Slide? - simplywall.stAmgenAmgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWSIlluminaIllumina Inc stock (US4523271090): gene sequencing player in focus after latest earnings and divesti - AD HOC NEWSMerck & Co.Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWSCharles RiverCharles River Labs stock (US14149Y1082): 4.45% slide puts support zone back in focus - AD HOC NEWS10x Genomics NewsThe Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance - simplywall.st

Archive

Latest Oldest
Total 11322
Page 487 / 629
Query --